HTHSCI 2H03 Lecture Notes - Lecture 11: Nateglinide, Neoplasm, Polyuria
10 Apr 2018
School
Department
Course
Professor
Document Summary
Hth sci 2h03 pharmacology of the endocrine system 2: drugs for the management of. Treatment thyroid cancer or multiple endocrine neoplasia syndrome the tab drug class should not be used in patients with renal disorders. Binds to the insulin receptors to regulate the metabolism of carboh. Subcutaneous insulin pump: delivers insulin via a pliable in the abdomen. Significant risk of hypoglycemia - this risk is increased with. Is sometimes cheaper than other therapies prolonged diabetes patients to go on insulin. Having to go on insulin should not be perceived as a f. Activates the sulfonylurea receptor on beta-cells to stimulate notes that sulfonylureas also increase the sensitivity of insulin recept. Sulfonylureas have a more rapid and pronounced ef. Meglitinides are more gentle (tutorial we learned tha insulin) Glimepiride: doses of 8 mg/day or higher achieved a 1. 2. Nateglinide: doses of 360 mg/day achieved a 0. 75% red. Moderate to significant risk of hypoglycemia wouldneedtoe .
